Key result
Mild post-TAVR paravalvular leak promotes platelet stress accumulation and elevated thrombogenic risk.
Why the study?
Persistent thrombotic events hamper TAVRs expansion to younger, lower-risk patients, prompting the need to link commonly acceptable mild paravalvular leak levels to thrombogenic risk.
Does mild paravalvular leak increase thrombogenic risk in TAVR models?
Does mild paravalvular leak increase thrombogenic risk in TAVR models?
Mild paravalvular leak after TAVR may carry a higher thrombogenic risk than previously recognized, highlighting the limitations of subjective clinical grading.
Mild PVL post-TAVR may confer unrecognized thrombogenic risk; hypothesis-generating from in silico models and should not yet change practice.
In recent years, the treatment of aortic stenosis with TAVR has rapidly expanded to younger and lower-risk patients. However, persistent thrombotic events such as stroke and valve thrombosis expose recipients to severe clinical complications that hamper TAVR's rapid advance. We presented a novel methodology for establishing a link between commonly acceptable mild paravalvular leak (PVL) levels through the device and increased thrombogenic risk. It utilizes in vitro patient-specific TAVR 3D-printed replicas evaluated for hydrodynamic performance. High-resolution µCT scans are used to reconstruct in silico FSI models of these replicas, in which multiple platelet trajectories are studied through the PVL channels to quantify thrombogenicity, showing that those are highly dependent on patient-specific flow conditions within the PVL channels. It demonstrates that platelets have the potential to enter the PVL channels multiple times over successive cardiac cycles, increasing the thrombogenic risk. This cannot be reliably approximated by standard hemodynamic parameters. It highlights the shortcomings of subjectively ranked PVL commonly used in clinical practice by indicating an increased thrombogenic risk in patient cases otherwise classified as mild PVL. It reiterates the need for more rigorous clinical evaluation for properly diagnosing thrombogenic risk in TAVR patients.
No takes yet. Share an insight, caveat, or question.
Kovarovic et al. (2023) studied Severe aortic valve stenosis with calcific aortic valve disease (n=5). Mild paravalvular leak (PVL) flows vs. Central forward flow (non-PVL flow paths) was evaluated on Platelet stress accumulation and percentage of platelets entering paravalvular leak channels. Mild paravalvular leak following TAVR generates complex flow dynamics that repeatedly entrain platelets and increase stress accumulation, indicating an unrecognized thrombogenic risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: